<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="8" ids="10033">Warfarin</z:chebi> is a commonly used <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> that has been associated with several significant cutaneous side effects, most notably <z:hpo ids='HP_0001038'>warfarin-induced skin necrosis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>A lesser known adverse reaction to <z:chebi fb="8" ids="10033">warfarin</z:chebi> is <z:chebi fb="8" ids="10033">warfarin</z:chebi>-induced venous limb <z:hpo ids='HP_0100758'>gangrene</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Both cutaneous adverse effects share the same pathophysiology, but are clinically quite different </plain></SENT>
<SENT sid="3" pm="."><plain>The majority of cases of <z:chebi fb="8" ids="10033">warfarin</z:chebi>-induced venous limb <z:hpo ids='HP_0100758'>gangrene</z:hpo> has been in patients with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> or <z:hpo ids='HP_0011874'>heparin-induced thrombocytopenia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>However, other hypercoagulable <z:mp ids='MP_0002054'>disease states</z:mp>, such as the <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome, can be associated with venous limb <z:hpo ids='HP_0100758'>gangrene</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>In order to increase recognition of this important condition, the authors report a case of <z:chebi fb="8" ids="10033">warfarin</z:chebi>-induced venous limb <z:hpo ids='HP_0100758'>gangrene</z:hpo> in a patient with presumed <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome and review the literature on <z:chebi fb="8" ids="10033">warfarin</z:chebi>-induced venous limb <z:hpo ids='HP_0100758'>gangrene</z:hpo> </plain></SENT>
</text></document>